Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 28 studies | 34% ± 14% | |
classical monocyte | 25 studies | 39% ± 16% | |
non-classical monocyte | 25 studies | 63% ± 17% | |
monocyte | 23 studies | 34% ± 12% | |
conventional dendritic cell | 14 studies | 28% ± 13% | |
myeloid cell | 11 studies | 31% ± 11% | |
microglial cell | 9 studies | 31% ± 12% | |
neutrophil | 8 studies | 33% ± 12% | |
alveolar macrophage | 7 studies | 25% ± 5% | |
dendritic cell | 7 studies | 29% ± 13% | |
mononuclear phagocyte | 5 studies | 27% ± 11% | |
intermediate monocyte | 4 studies | 49% ± 21% | |
GABAergic neuron | 3 studies | 29% ± 4% | |
glutamatergic neuron | 3 studies | 34% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 98% | 436.93 | 177 / 180 | 98% | 17.68 | 423 / 430 |
breast | 98% | 448.18 | 448 / 459 | 98% | 13.76 | 1095 / 1118 |
lung | 100% | 1218.91 | 578 / 578 | 94% | 15.97 | 1083 / 1155 |
brain | 92% | 533.46 | 2437 / 2642 | 99% | 16.63 | 699 / 705 |
kidney | 97% | 479.21 | 86 / 89 | 95% | 17.97 | 852 / 901 |
thymus | 97% | 449.01 | 636 / 653 | 94% | 8.76 | 566 / 605 |
prostate | 100% | 573.77 | 245 / 245 | 86% | 5.62 | 434 / 502 |
uterus | 97% | 408.38 | 165 / 170 | 82% | 8.34 | 377 / 459 |
intestine | 98% | 369.29 | 942 / 966 | 72% | 8.21 | 379 / 527 |
bladder | 100% | 893.29 | 21 / 21 | 67% | 8.33 | 340 / 504 |
adrenal gland | 95% | 400.09 | 246 / 258 | 69% | 4.71 | 159 / 230 |
skin | 63% | 166.57 | 1138 / 1809 | 90% | 14.09 | 423 / 472 |
esophagus | 75% | 252.50 | 1086 / 1445 | 72% | 6.26 | 131 / 183 |
stomach | 65% | 207.93 | 235 / 359 | 80% | 10.50 | 230 / 286 |
pancreas | 39% | 94.91 | 127 / 328 | 90% | 13.82 | 160 / 178 |
liver | 67% | 192.08 | 151 / 226 | 61% | 4.63 | 249 / 406 |
spleen | 100% | 1538.50 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 5945.77 | 926 / 929 | 0% | 0 | 0 / 0 |
adipose | 99% | 635.40 | 1191 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 36.51 | 28 / 29 |
blood vessel | 94% | 459.61 | 1260 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 12.12 | 38 / 45 |
heart | 54% | 139.77 | 464 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 51% | 3.53 | 41 / 80 |
muscle | 44% | 106.05 | 357 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0042288 | Molecular function | MHC class I protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PILRA |
Protein name | Paired immunoglobin like type 2 receptor alpha Paired immunoglobulin-like type 2 receptor alpha (Cell surface receptor FDF03) (Inhibitory receptor PILR-alpha) |
Synonyms | |
Description | FUNCTION: Paired receptors consist of highly related activating and inhibitory receptors and are widely involved in the regulation of the immune system. PILRA is thought to act as a cellular signaling inhibitory receptor by recruiting cytoplasmic phosphatases like PTPN6/SHP-1 and PTPN11/SHP-2 via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules. Receptor for PIANP. .; FUNCTION: (Microbial infection) Acts as an entry co-receptor for herpes simplex virus 1. . |
Accessions | ENST00000394000.6 [Q9UKJ1-4] ENST00000453419.5 C9JGG1 C9JJ79 ENST00000350573.2 [Q9UKJ1-3] Q9UKJ1 ENST00000198536.7 [Q9UKJ1-1] ENST00000432297.6 |